Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.632 EUR -2.16% Market Closed
Market Cap: 150.5m EUR

Intrinsic Value

The intrinsic value of one IPH stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.632 EUR, Innate Pharma SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

IPH Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Innate Pharma SA

Intrinsic Value History
Dive into the past to invest in the future

IPH looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if IPH is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about IPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Innate Pharma SA.

Explain Valuation
Compare IPH to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innate Pharma SA

Current Assets 65m
Cash & Short-Term Investments 60m
Receivables 5m
Other Current Assets 23k
Non-Current Assets 28m
Long-Term Investments 10m
PP&E 5m
Other Non-Current Assets 13m
Current Liabilities 29m
Accounts Payable 16.6m
Accrued Liabilities 6.6m
Short-Term Debt 6.8m
Other Current Liabilities -965k
Non-Current Liabilities 59m
Long-Term Debt 53m
Other Non-Current Liabilities 6m
Efficiency

Free Cash Flow Analysis
Innate Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Innate Pharma SA

Revenue
6m EUR
Cost of Revenue
-3m EUR
Gross Profit
3m EUR
Operating Expenses
-53m EUR
Operating Income
-50m EUR
Other Expenses
4m EUR
Net Income
-46m EUR
Fundamental Scores

IPH Profitability Score
Profitability Due Diligence

Innate Pharma SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Strong 3Y Average Gross Margin
Healthy Gross Margin
Declining Gross Margin
Declining Net Margin
hidden
Profitability
Score

Innate Pharma SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

IPH Solvency Score
Solvency Due Diligence

Innate Pharma SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
hidden
Solvency
Score

Innate Pharma SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IPH Price Targets Summary
Innate Pharma SA

Wall Street analysts forecast IPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPH is 4.995 EUR with a low forecast of 2.414 EUR and a high forecast of 6.51 EUR.

Lowest
Price Target
2.414 EUR
48% Upside
Average
Price Target
4.995 EUR
206% Upside
Highest
Price Target
6.51 EUR
299% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Innate Pharma SA
does not pay dividends
Shareholder Yield

Current shareholder yield for IPH is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IPH stock?

The intrinsic value of one IPH stock under the Base Case scenario is hidden EUR.

Is IPH stock undervalued or overvalued?

Compared to the current market price of 1.632 EUR, Innate Pharma SA is hidden .

Back to Top